Evidence born in reality,
validated by rigour

Interpreting evidence from real-world sources to quantify and strengthen outcomes and support data-driven decisions across the healthcare ecosystem.

Integrating real-world data into the economics of care

Integrating real-world data into the economics of care

At Becoya, we transform complex, fragmented health data into meaningful evidence that informs payer, provider, and policy decisions. Our work bridges clinical realities with economic insight, delivering scientifically robust, contextually relevant evidence that defines product value and drives access across diverse markets.

Real-world Evidence Analysis
Driven by Clinical & Statistical Rigour

Retrospective Database Studies

We analyse large-scale health databases to uncover utilisation trends, treatment outcomes, and cost drivers through methodologically rigorous, statistically validated approaches.

Patient-Reported And Clinician-Reported Outcomes

We design and implement outcome frameworks that reflect both patient and clinician perspectives, capturing the real impact of treatment on daily life and clinical decision-making.

Comparative Effectiveness Research (CER)

We evaluate treatment performance across therapies using real-world data, identifying comparative advantages that inform formulary inclusion, clinical practice, and access strategy.

Burden Of Illness Studies

We quantify the full clinical, economic, and humanistic burden of disease to highlight unmet needs and inform resource allocation.

Treatment Pattern And Drug Utilisation Studies

We assess prescribing patterns, adherence, and switching behaviour to provide evidence that refines positioning, strengthens reimbursement narratives and defines local standards of care.

Natural History Of Disease Studies

We map the natural course of disease progression using real-world datasets, generating insights that guide clinical design and endpoint selection.

Explore our Health
Economics suite

Economic Modelling & Health Technology Assessments

We develop localised health-economic models tailored to the needs of payers across national and local levels.

Evidence Synthesis & Meta-analysis

We combine literature, network meta-analysis and indirect comparisons to generate quantitative insights supporting launch and commercial strategy.

Insights designed
for execution

Navigating the UAE’s Regulatory Shift: From Ambition to

The Future of Biopharma: China and Saudi Arabia are redefining “Pharmerging”

Strategic Defense against Generic Entry for Rare Disease Products in KSA

Let's talk

Whether you're expanding into the region or rethinking your local strategy, we're here to help.

Let's talk

Whether you're expanding into the region or rethinking your local strategy, we're here to help.

lets_talk